Showing results (21-30 of 97) with videos related to
Sort By:
Pageof 10
Journal of Clinical Microbiology|August 28, 2009
Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methodsKerrie Eastwood, Patrick Else, André Charlett, et al.Journal of Clinical Medicine|February 15, 2022
Frozen Blastocyst Embryo Transfer: Comparison of Protocols and Factors Influencing OutcomeAikaterini Eleftheriadou, Abraham Francis, Mark Wilcox, et al.Journal of Medical Microbiology|May 16, 2019
Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosisNada S Alghamdi, Richard Barton, Mark Wilcox, et al.Respiratory Medicine|May 31, 2021
Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trialManjunath P Pai, Mark Wilcox, Surya Chitra, et al.Expert Review of Anti-Infective Therapy|December 21, 2012
Epidemiology, diagnosis and treatment of Clostridium difficile infectionMatteo Bassetti, Giovanni Villa, Davide Pecori, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 3, 2010
Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphismTimothy Planche, Derek C Macallan, Toni Sobande, et al.The Journal of Antimicrobial Chemotherapy|July 5, 2012
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over timeGwenan M Knight, Emma L Budd, Laura Whitney, et al.Sexually Transmitted Infections|October 14, 2010
Positive predictive value of the Becton Dickinson VIPER system and the ProbeTec GC Q x assay, in extracted mode, for detection of Neisseria gonorrhoeaeCassie F Pope, Phillip Hay, Sarah Alexander, et al.Open Forum Infectious Diseases|November 18, 2020
An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile InfectionKerrie Davies, Damian Mawer, A Sarah Walker, et al.BMC Infectious Diseases|April 17, 2015
A randomised phase 1 study to investigate safety, pharmacokinetics and impact on gut microbiota following single and multiple oral doses in healthy male subjects of SMT19969, a novel agent for Clostridium difficile infectionsRichard Vickers, Neil Robinson, Emma Best, et al.Pageof 10